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Compartmentalization of prion isoforms within the reproductive tract of the ram
Abstract
Cellular prion protein (Prp(C)) is a glycoprotein usually associated with membranes via its
glycosylphosphatidylinositol (GPI) anchor. The trans-conformational form of this protein (Prp(SC)) is the
suggested agent responsible for transmissible neurodegenerative spongiform encephalopathies. This
protein has been shown on sperm and in the reproductive fluids of males. Antibodies directed against the
C-terminal sequence near the GPI-anchor site, an N-terminal sequence, and against the whole protein
showed that the Prp isoforms were compartmentalized within the reproductive tract of the ram.
Immunoblotting with the three antibodies showed that the complete protein and both N- and C-terminally
truncated and glycosylated isoforms are present within cauda epididymal fluid and seminal plasma.
Moreover, we demonstrate that in these fluids, the Prp(C) isoforms are both in a soluble state as well as
associated with small membranous vesicles (epididymosomes). We also report that only one major
glycosylated 25 kDa C-terminally truncated Prp(C) isoform is associated with sperm from the testis,
cauda epididymis, and semen, and this form is also present in the sperm cytoplasmic droplets that are
released during maturation. In sperm, this C-terminal truncated form was found to be associated with
membrane lipid rafts present in the mature sperm, suggesting a role for it in the terminal stages of sperm
maturation.
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ABSTRACT

similarity at the amino acid level being between 85% and
97% among mammals [4]. The glycoprotein possesses two
N-linked glycosylation sites and exists in biglycosylated,
monoglycosylated, and nonglycosylated forms [5, 6]. This,
as well as proteolytic cleavage within the N-terminal and
C-terminal regions of the protein, result in a number of
different isoforms being expressed within the various tissues in which the protein is found [7]. Indeed, the expression of PrpC is not restricted to nervous tissues; PrpC is a
ubiquitous protein present in almost all tissues throughout
the body [8, 9]. PrpC also usually contains a C-terminal
glycosyl-phosphatidyl-inositol (GPI) anchor that enables it
to associate with membranes [10, 11]. It has been found to
be enriched in sphingolipid- and cholesterol-rich membrane
microdomains, known as lipid rafts [12], which are characterized by their relative insolubility at low temperatures
in nonionic detergents such as Triton X-100. It has been
suggested that this association with lipid rafts is critical for
the conformational conversion of PrpC to PrpSC [13, 14]. In
vitro, PrpC can be released from the cell surface via the
action of exogenous bacterial phosphatidylinositol-specific
phospholipase C (PI-PLC), and in vivo soluble forms of the
PrpC protein lacking the glycolipid moiety have been reported in serum and human cerebrospinal fluid [15–17].
Despite widespread attention, the cellular function of the
Prp remains enigmatic. Previous studies have associated the
high levels of expression of PrpC in neuronal cells with a
physiological role in synaptic transmission. The protein has
been shown to bind metals, particularly copper, via the multiple octa-peptide repeats present in the NH2 terminus region [18–20]. This property may in part account for its
antioxidant activity, which has led to reports suggesting a
role in inhibiting apoptosis [21]. PrpC has also been implicated in signal transduction because of its position in the
external face of the plasma membrane of cells [22, 23], its
association with membrane lipid rafts [12], and studies
showing its direct interaction with signaling proteins [24,
25].
Our laboratory has previously shown that PrpC is associated with ram sperm [26], a finding consistent with other
results indicating that the protein is present in human, bovine, mouse, and hamster sperm [27]. However, at least in
human sperm, there is conflicting data as to the isoform(s)
present. Although one study has suggested that the protein
is C-terminally truncated (being anchored by its N-terminus
independent of a GPI-link) and not associated with lipid
rafts [27], a more recent study suggested that it is GPIanchored and N-terminally truncated [28]. Furthermore, we
have also shown that different Prp isoforms are present in
the ram genital tract fluids and may be processed during
epididymal maturation [26]. It remained to be established
whether certain isoforms may be transferred from the fluid

Cellular prion protein (Prp ) is a glycoprotein usually associated with membranes via its glycosylphosphatidylinositol (GPI)
anchor. The trans-conformational form of this protein (PrpSC) is
the suggested agent responsible for transmissible neurodegenerative spongiform encephalopathies. This protein has been
shown on sperm and in the reproductive fluids of males. Antibodies directed against the C-terminal sequence near the GPIanchor site, an N-terminal sequence, and against the whole protein showed that the Prp isoforms were compartmentalized
within the reproductive tract of the ram. Immunoblotting with
the three antibodies showed that the complete protein and both
N- and C-terminally truncated and glycosylated isoforms are
present within cauda epididymal fluid and seminal plasma.
Moreover, we demonstrate that in these fluids, the PrpC isoforms
are both in a soluble state as well as associated with small membranous vesicles (epididymosomes). We also report that only one
major glycosylated 25 kDa C-terminally truncated PrpC isoform
is associated with sperm from the testis, cauda epididymis, and
semen, and this form is also present in the sperm cytoplasmic
droplets that are released during maturation. In sperm, this Cterminal truncated form was found to be associated with membrane lipid rafts present in the mature sperm, suggesting a role
for it in the terminal stages of sperm maturation.
C
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INTRODUCTION

The prion protein (Prp) represents a novel mechanism of
disease propagation and is based on the conversion of a
normal cellular prion protein (PrpC) into a transmissible
pathological form (PrpSC) [reviewed in 1, 2]. This transconformation is produced by an autocatalytic process induced by PrpSC itself and is the mechanism responsible for
the transmissible spongiform encephalopathies such as bovine spongiform encephalopathy (BSE), scrapie in sheep,
and the human equivalent, Creutzfeldt-Jakob disease. Infection is mediated, devoid of nucleic acid, by passage of
PrpSC from host to host (the protein-only hypothesis), provided they contain a functional Prnp gene [1–3].
PrpC is highly conserved among mammalian species: the
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to the sperm. Such a mechanism may be facilitated by hydrophobic membrane vesicles arising from the epididymal
epithelium. These vesicles, named ‘‘epididymosomes’’
[29], appear to be similar to seminal plasma prostasomes,
and they may enable the transport of specific hydrophobic
proteins within the reproductive fluid and their transfer to
sperm.
In light of these data, we conducted immunological and
biochemical studies to characterize the PrpC isoforms present in both the reproductive fluids and sperm from the ram.
To do so, we raised antibodies directed against a C-terminal
linear peptide sequence (close to the GPI-anchor site) and
the recombinant sheep Prp (VRQ allele). With these antibodies and a monoclonal antibody directed against the Nterminal of the protein, we clearly demonstrate that both
glycosylated and proteolytic isoforms of PrpC are present
in the male reproductive tract. However, the main isoforms
differ between sperm and the reproductive fluid, suggesting
only a low extent of exchange between these two compartments. We also show that a large part of sperm Prp is
associated with the cytoplasmic droplet and that the Prp
present in mature sperm is associated with lipid rafts. In
the fluid, PrpC isoforms were found in epididymosome vesicles and also in a soluble form, suggesting another type(s)
of association to maintain this hydrophobic protein in solution.
MATERIALS AND METHODS

Generation of Antibodies
The mouse monoclonal antibody (P4) directed against an N-terminal
peptide was generously donated by Dr. M. Groschup (INEID, GreifswaldInsel Riems, Germany) [30] and is referred to as P4-NT in the text. The
rabbit anti-Prp polyclonal antibody 179-CT was raised against the linear
peptide 218-ITQYQRESQAYYQRGA-233 corresponding to a C-terminal
amino acid sequence of the mature ovine protein, which is situated just
before Ser234 bearing the GPI-anchor site. The polyclonal antibody 172Full was obtained against the complete ovine recombinant Prp protein [31]
(VRQ allele; a kind gift from Dr. D. Marc, INRA-Nouzilly, France). Before the first injection, serum from different rabbits were tested on fluids
from various epididymal regions by immunoblotting. Animals presenting
no reactions were chosen for immunization with either the peptide or recombinant protein. The initial injection included Freund complete adjuvant; 3 wk later, the first boost, including incomplete adjuvant, was given,
followed by two more boosts at intervals of 15 days. The last serum
collected was used for the experiments.

Biological Samples
Experiments on animals were conducted according to the International
Guiding Principles for Biomedical Research Involving Animals as promulgated by the Society for the Study of Reproduction.
Testicular and epididymal fluid and spermatozoa were collected from
adult Ile-de-France or Romanov rams as described previously [26, 32].
Ejaculated sperm and seminal plasma were collected with an artificial vagina. Spermatozoa were separated from the fluid by centrifugation (5000
3 g, 10 min, 48C); the fluids were then collected and centrifuged again
(15 000 3 g, 10 min, 48C) and then stored at 2208C. The sperm were
subsequently washed twice by adding PBS (5000 3 g, 10 min, 48C).
Where indicated, the spermatozoa collected from the cauda epididymis or
from semen were placed directly on top of a 10%–80% (v/v) linear Percoll
gradient and centrifuged (3000 3 g, 15 min, 48C) in order to remove the
cytoplasmic droplets. The fraction corresponding to the cytoplasmic droplets was found at approximately 30% Percoll, and the sperm were at the
bottom of the gradient. The sperm and cytoplasmic droplets were then
washed twice with PBS as described above. Proteins were extracted by
addition of an equal volume of nonreducing gel sample buffer to the pellet
and centrifuging the sample (15 000 3 g, 10 min, 48C). The resulting
supernatants were stored at 2208C. Before loading on gels, the samples
were mixed with an equal volume of reduced gel sample buffer and heated
(958C, 5 min).
Brains from a healthy sheep and a sheep with scrapie were homoge-

nized in a 10% (w/v) lysis solution [33], diluted 50% with sample buffer,
and heated (958C, 5 min) before gel loading.

Proteolytic Cleavage of Recombinant Ovine Prp
Purified recombinant ovine Prp was cleaved by trypsin (ratio 1/1000
w/w; Roche, Meylan, France) as described previously [31]. After 1 h at
378C, the reaction was stopped by addition of reducing sample buffer and
heating at 958C for 5 min. The samples were loaded onto gels directly or
stored at 2208C.

Preparation of Epididymosomes and Seminosomes
Membrane vesicles from the cauda epididymal plasma and seminal
plasma were prepared essentially as previously described [34, 35]. Briefly,
cauda epididymal fluid or seminal plasma—freed of spermatozoa and contaminating debris by two successive centrifugations at 15 000 3 g (10
min, 48C)—were ultracentrifuged at 45 000 3 g for 2 h at 48C (J18; Beckman, Villepinte, France). The high-speed supernatant (HSS) was retained,
and the pellet containing the membrane vesicles was suspended in a volume of PBS equal to the initial volume of fluid and centrifuged again
under the same conditions. The final pellet was either resuspended in PBS
or the proteins extracted directly by addition of reducing sample buffer
and heating (958C, 5 min). The samples were loaded onto gels directly or
stored at 2208C.

Triton X-114 Phase Partitioning
Triton X-114 precondensation and phase partitioning was performed
as described previously [36]. Briefly, samples were mixed with 1.0% (v/
v) Triton X-114 in 10 mM Tris-HCl, 150 mM NaCl, pH 7.4 and left on
ice for 20 min. Samples were centrifuged, and a 50 ml aliquot of the
supernatant (maximum of 0.5 mg of protein) was layered on top of a 6%
(w/v) sucrose cushion (10 mM Tris-HCl, 150 mM NaCl, 0.06% v/v Triton
X-114, pH 7.4), incubated for 3 min at 308C, and then centrifuged (3000
3 g, 308C, 5 min). The upper aqueous phase was retained, and fresh Triton
X-114 was added to a final concentration of 0.5% (v/v). The samples were
mixed and left on ice for 5 min before layering on top of the same sucrose
cushion and repeating the phase partitioning procedure. After the centrifugation, the aqueous phase was again retained, adjusted to a final concentration of 2.0% (v/v) Triton X-114, mixed and left on ice (5 min),
incubated (308C, 3 min), centrifuged (3000 3 g, 308C, 5 min), and then
removed to a fresh tube. The sucrose cushion was removed from the detergent phase, and then it was made up to the same volume as the aqueous
phase by adding 10 mM Tris-HCl, 150 mM NaCl, pH 7.4.

Protein Deglycosylation
Fluids and proteins extracted from sperm or epididymosomes were
boiled in the presence of 1% (v/v) 2-mercaptoethanol and 0.2% (w/v) SDS
for 5 min and then incubated for 2 h at 378C in the presence of 2% (w/
v) CHAPS, 5 mM EDTA, and 5 U of N-glycosidase F (Roche). At the
end of the incubation, the reaction was stopped by addition of an equal
volume of reduced gel sample buffer and then heating the sample for 5
min at 958C. In some experiments, the proteins present in reduced sample
buffer were deglycosylated by adding 2% (w/v) CHAPS, 5 mM EDTA,
and 5 U of N-glycosidase F and incubating for 2 h at 378C. The reaction
was stopped by heating the sample for 5 min at 958C. Negative controls
were conducted by replacing the N-glycosidase F in the reaction mix with
an equal volume of H20.

Preparation of Lipid Raft
All procedures were carried out at 48C and were based on those published previously [37] with minor modifications. Sperm purified by Percoll
gradient centrifugation (as described above) and washed twice with PBS
were resuspended in 1% (v/v) Triton X-100 extraction buffer containing
150 mM NaCl, 50 mM HEPES pH 7.4, 1 mM EDTA, 1 mM EGTA, 1
mM Na3VO4, 20 mM NaF, 0.1 mM PMSF, and protease inhibitor cocktail
(Sigma, Saint Quentin Fallavier, France). The sperm concentration used
was 108 sperm/ml. The homogenate was made 45% (w/v) sucrose by addition of an equal volume of 90% (w/v) sucrose in Buffer A (25 mM
Hepes pH 7.4, 150 mM NaCl, 1 mM Na3VO4) and then 1 ml loaded at
the bottom of an ultracentrifuge tube. Layers of sucrose were carefully
added (2.5 ml of 30% w/v sucrose in Buffer A and then 2 ml of 5% w/v
sucrose in Buffer A). The gradients were centrifuged for 14 h at 100 000
3 g in an SW50.1 rotor (Beckman) at 48C and subsequently separated
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FIG. 2. Prp in the reproductive fluid of the ram. Testicular fluid and fluid
from the different zones of the epididymis (0–9) were collected as described previously [26, 32]. The proteins were separated by SDS-PAGE
and immunoblotted with the three anti-Prp antibodies.

FIG. 1. The specificity of the anti-Prp antibodies. A) Brain extracts from
healthy and PrpSC-infected (scrapie) sheep and (B) tryptic cleavage products of the recombinant ovine VRQ protein were separated by SDS-PAGE
and immunoblotted with the P4-NT, 172-Full, and 179-CT antibodies. C)
A schematic diagram showing the localization of the epitopes recognized
by the P4-NT and 179-CT antibodies. The 172-Full polyclonal antibody
recognizes epitopes all along the protein.

into nine fractions (0.6 ml per fraction), with fraction 9 containing the
highest density of sucrose (bottom). In some experiments the fractions
were collected, diluted 1:10 with Buffer A, and subjected to a second
centrifugation for 2 h at 100 000 3 g in the SW50.1 rotor at 48C to
concentrate the lipid raft. The presence of pellets in each fraction after this
centrifugation was noted, and then the proteins were extracted directly by
resuspending in reduced gel sample buffer and heating (958C, 5 min). The
samples were loaded directly onto the gels or stored at 2208C.

Gel Electrophoresis and Immunoblotting
The methods of SDS-PAGE have been described earlier [38]. SDSPAGE was conducted on 6%–16% or 10%–20% gradient gels. Gels were
first stained with Coomassie blue, and the volume of each sample was
adjusted such that equal amounts of protein were loaded into each lane.
The proteins were semi–dry transferred to nitrocellulose over 2 h at 0.8
mA/cm2. All membranes were stained with Ponceau-Red to visualize the
proteins on the membrane, rinsed in TBS containing 0.05% (v/v) Tween
(TBS-T), and then blocked with TBS-T supplemented with 5% (w/v) lyophilized skim milk for 1 h at room temperature. The membranes were
rinsed and incubated in TBS-T containing 5% (w/v) milk and primary
antibody (179, 1/2000; 172 and P4, 1/4000) overnight at 48C. The blots
were washed 4 times (10 min) with TBS-T, incubated in secondary antibody conjugated to peroxidase (goat anti-rabbit [Sigma] or goat antimouse [Jackson Laboratories, West Grove, PA]; 1/5000) for 1 h at room
temperature, and then washed again in TBS-T. The labeled proteins were
detected using a chemiluminescent substrate (West-dura; Pierce, Rockford,
IL), and the images were recorded on a digital image analysis station.
Immunoblots shown in the results are representative of the three or more
replicates carried out for each experiment using material from different
animals. No reactive bands were found when the membranes were incubated with the secondary antibodies alone (data not shown).

RESULTS
Characterization of the Anti-Prp Antibodies
We have generated two antibodies directed against different sites of the Prp protein. We first used these antibodies

to probe extracts obtained from brains of healthy sheep and
sheep with scrapie (Fig. 1A). The P4-NT monoclonal antibody recognized the classical protein-banding pattern of
35, 30–32, and 28 kDa in both brain extracts, corresponding to the biglycosylated, the two monoglycosylated, and
the nonglycosylated forms, respectively. The polyclonal antibodies 172-Full and 179-CT recognized these same bands.
Furthermore, the same extracts probed with preimmune serum for 172-Full and 179-CT did not reveal any bands (data
not shown).
In order to confirm the regional specificity of these antibodies, proteolytic cleavage of the recombinant ovine
VRQ protein was performed with trypsin. Conditions were
chosen such that the proteolysis was limited to generate
only two main fragments: a 15 kDa C-terminal fragment
and a 10 kDa N-terminal fragment [31]. All antibodies recognized clearly the 25 kDa recombinant protein (Fig. 1B).
As expected, the polyclonal antibody 172-Full also recognized the two bands at 10 and 15 kDa obtained after limited
proteolysis. The N-terminally directed P4-NT monoclonal
antibody recognized only the 10 kDa cleavage product,
whereas the polyclonal antibody 179-CT reacted only with
the 15 kDa fragment. Similar results were obtained when
chymotrypsin was used instead of trypsin to cleave the recombinant protein. The regional specificity of the anti-Prp
antibodies are diagrammatically shown in Figure 1C.
Prp in the Reproductive Fluid of the Ram

With all three antibodies, two main immunoreactive
bands were mainly found in the fluids from the cauda epididymis (zones 7–9; Fig. 2): a main band at about 43 kDa
and another heterodisperse band at 35 kDa. A third band
of 28 kDa was also weakly detected by all three antibodies,
although it varied between animals (see also Fig. 3). Similarly, the 35 kDa band was found to vary between animals,
with some showing strong immunoreactivity and others
lower levels. This variation was mainly noted with the
polyclonal antibodies. In more proximal regions of the epididymis, only slight reactive bands were observed, but
these bands were variable in different animals.
We next addressed the mechanism by which this hydrophobic protein is transported in the fluid. The cauda epididymal fluid was subjected to high-speed centrifugation in
order to pellet the membrane vesicles (or epididymosomes)
that are present in this fluid (see Materials and Methods).
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reactive with the P4-NT and 172-Full antibodies. Membrane vesicles, arising from the cauda epididymal fluid and
the different accessory glands, were found in the pellet obtained after high-speed centrifugation (seminosomes, SMS).
All three antibodies reacted strongly with the 43 and 30
kDa forms, and the 172-Full and 179-CT antibodies also
reacted with a lower molecular mass form at about 28 kDa
that was not detected in the fluid. Interestingly, this 28 kDa
band was not reactive with the P4-NT antibody. These results indicate that in the seminal plasma a proteolytic processing occurs that degrades the prion isoforms both in the
fluid and on the membrane vesicles.

FIG. 3. Compartmentalization of Prp within the reproductive fluid of the
ram. A) Cauda epididymal plasma (CEP) and (B) seminal plasma (SP) of
the ram were subjected to high-speed centrifugation, and the proteins
from the supernatant (HSS) and membrane pellets, corresponding to epididymosomes (EPS) and seminosomes (SMS), were separated via SDSPAGE and immunoblotted with the three anti-Prp antibodies.

By electron microscopy, this pellet was found to be composed of a homogenous population of membrane vesicles
25–50 nm in diameter [39]. Figure 3A shows that similar
patterns of prion reactivity were detected with all three antibodies in the fluid before (cauda epididymal plasma, CEP)
and after (HSS) high-speed centrifugation, and in the pellet
(epididymosomes, EPS). A similar profile of prion reactivity was found in the supernatant following centrifugation
at 100 000 3 g (data not shown). Again, the immunoreactivity of the polyclonal antibodies 172-Full and 179-CT to
the 35 kDa band was found to vary in the fluid before or
after centrifugation; however, they always reacted strongly
with this band in the epididymosomes.
A similar experiment was conducted with seminal plasma in order to establish whether there are changes in the
types or in the distribution of the prion isoforms upon ejaculation (Fig. 3B). The 43 kDa band was still present in
seminal plasma before (SP) and after (HSS) high-speed
centrifugation, although at lower quantities such that the
179-CT antibody only faintly detected it. The 35 kDa band
was not detected in this fluid before or after centrifugation,
and a lower molecular mass band at about 30 kDa became
FIG. 4. Prp exists in a number of different isoforms in the male reproductive fluid. Following high-speed centrifugation,
proteins from the HSS and epididymosomes (EPS) were deglycosylated by treating them with N-glycosidase F. The proteins were subjected to SDS-PAGE and immunoblotted with the three anti-Prp antibodies. The C-terminally truncated (*) and
N-terminally truncated (**) isoforms of Prp
are shown.

Deglycosylation of Prp in Male Reproductive Fluid
We tried to better resolve the individual isoforms present
in the cauda epididymal compartments. The high-speed supernatant (HSS) and vesicle pellet (EPS) were treated with
N-glycosidase F in order to remove N-linked oligosaccharides from proteins (Fig. 4). Following deglycosylation, all
three antibodies detected bands at approximately 35 and 25
kDa in both the HSS and EPS, suggesting that they represent full-length Prp isoforms. The 172-Full antibody also
detected minor bands of 20 and 18 kDa in the HSS, and
the 20 kDa in the EPS. This 20 kDa band was also detected
by the P4-NT antibody, but either was only slightly reactive
(HSS) or not detected (EPS) by the 179-CT antibody. Thus,
this 20 kDa band could correspond to a C-terminal truncated isoform. Alternatively, although the 179-CT antibody
was immunoreactive against the 18 kDa band in the HSS,
the P4-NT antibody did not detect it, indicating that it represents an N-terminally truncated isoform. It is most likely
that the higher reactive band at 35 kDa has not undergone
full deglycosylation.
Prp in the Reproductive Fluid Partitions into
the Detergent-Rich Phase after Triton X-114 Extraction
Because full-length Prp is both ‘soluble’ and associated
with epididymosomes, it was of interest to investigate
whether the soluble protein retains its GPI-anchor. It has
been shown that intact PrpC anchored to the membrane by
a GPI anchor is found in the detergent-rich phase after Triton X-114 phase partitioning, but remains in the aqueous
phase when the GPI anchor is absent [36, 40]. When the
HSS and epididymosomes (EPS) were subjected to Triton
X-114 phase separation, all of the Prp was detected in the
detergent-rich phase after immunoblotting with the 172Full antibody (Fig. 5). Similar results were obtained with
the P4-NT and 179-CT antibodies; no prion reactivity was
found in the aqueous phase after the phase separation.
Prp Is Associated with Ram Sperm
Prp associated with ram sperm was investigated using
the three antibodies (Fig. 6A). Immunoblotting of testicular
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FIG. 5. Triton X-114 Prp phase partitioning of Prp in the male reproductive fluid. The HSS and epididymosome extracts (EPS) were subjected
to Triton X-114 phase separation. The detergent-rich phase (DT) and aqueous phase (AQ) were collected, separated by SDS-PAGE, and immunoblotted with the anti-Prp antibody 172-Full.

(T), caudal (Cd), and ejaculated (Ej) sperm extracts resulted
in the detection of one major immunoreactive band at 24–
25 kDa by the P4-NT and 172-Full antibodies. When the
179-CT antibody was used, this band was only slightly reactive with extracts from testicular sperm and was not detected in caudal or ejaculated sperm. A minor band of about
40 kDa was detected by the P4-NT and 172-Full antibodies
in all three sperm extracts upon longer exposure (data not
shown); however, the 179-CT antibody did not react with
this band.
Because fully matured sperm capable of fertilization are
devoid of their cytoplasmic droplets, we investigated the
association of prion isoforms with ram caudal sperm separated from these droplets. Figure 6B shows that both the
P4-NT and 172-Full antibodies detected the single 24–25
kDa protein band in protein extracts prepared from sperm
before and after Percoll gradient centrifugation, and this
band was also the major isoform found in cytoplasmic
droplets. Furthermore, the 40 kDa band was easily detected
by both antibodies in the extracts prepared from the cytoplasmic droplet, indicating that it is concentrated within
these droplets. A minor band of 22 kDa was detected by
the P4-NT antibody in the cytoplasmic droplet extracts; it
may represent a further C-terminally truncated isoform not
detected by the 172-Full antibody. Deglycosylation of
sperm and cytoplasmic droplet extracts resulted in a shift
in the apparent molecular mass of this 24–25 kDa band to
approximately 17 kDa (Fig. 6C). The 179-CT antibody did
not recognize any of these bands either before or after deglycosylation (data not shown). Furthermore, the 24–25
kDa prion isoform remained in the pellet following extraction of sperm with Triton X-114, suggesting that it is not
anchored to the membrane by a GPI-anchor (data not
shown).
Prp in Ram Sperm Is in Lipid Rafts

PrpC can be associated with lipid rafts [12], but a previous study suggested that it is not found in these structures
in hamster epididymal sperm [27]. To clarify whether it was
associated with these cellular microdomains in cauda epididymal sperm, purified by Percoll gradient centrifugation,
proteins were extracted with cold Triton X-100 and the extract subjected to a flotation assay (Fig. 7A). The 24–25
kDa protein was detected by the P4-NT antibody in the
buoyant fractions (fractions 4–5, corresponding to the 5%–
30% sucrose interface) of the sucrose gradient. Flotillin, a
characteristic marker of membrane lipid rafts, was also detected in the same region (fractions 4–6), indicating that it
contained lipid rafts. Furthermore, when the same sucrose
gradient fractions were immunoblotted with an antibody

FIG. 6. Prp is associated with ram sperm. A) Testicular (T), cauda epididymal (Cd), and ejaculated (Ej) sperm extracts were separated by SDSPAGE and immunoblotted with the three anti-Prp antibodies. B) Extracts
from cauda epididymal sperm before (NP) and after Percoll-gradient separation (P) and the isolated cytoplasmic droplets (CD) were probed with
the 172-Full and P4-NT antibodies. C) Extracts from cauda epididymal
sperm (Cauda Sp) and the isolated cytoplasmic droplets (Cyt Drops) were
treated with N-glycosidase F.

against the transmembrane protein angiotensin converting
enzyme, the majority of the reactivity was restricted to fractions collected from the base of the gradient, indicating that
the association of Prp and flotillin with these buoyant fractions is not due to incomplete solubilization of membrane
fragments during the extraction process. Moreover, when
the main flotillin reactive fraction from the sucrose gradient
(fraction 4 [F.4]) was centrifuged in order to pellet the raft,
both Prp and flotillin were found associated with the pellet
(Fig. 7B). Deglycosylation of the raft pellets resulted in a
shift in the molecular mass of the Prp to 17 kDa (Fig. 7C),
indicating that it is the same isoform as that present in the
cytoplasmic droplets (see Fig. 6C).
DISCUSSION

In this study, we have addressed the biochemical characteristics of Prp isoforms present in the male reproductive
tract. The results demonstrate that full-length, as well as
truncated N-terminal and C-terminal, isoforms exist within
the reproductive fluid, and a C-terminally truncated isoform
is associated with ram sperm. Significantly, we found that
the prion isoforms are compartmentalized within the male
reproductive tract. The majority of the Prp was found in
the fluid where it is transported both bound to membrane
vesicles (epididymosomes) and as a soluble species. Furthermore, our results show that distinct cellular lipid microdomains known as lipid rafts are present in the mature
male gamete, and that a C-terminally truncated prion iso-
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FIG. 7. Prp in ram sperm is associated with lipid rafts. Proteins from
cauda epididymal sperm, purified by Percoll gradient centrifugation, were
extracted with ice-cold Triton X-100 and subjected to a flotation assay
through a sucrose gradient. Following centrifugation, nine fractions (1–9)
were collected (9, bottom fraction). A) An equivalent volume from each
fraction was separated by SDS-PAGE and immunoblotted with the antiPrp P4-NT antibody, an anti-flotillin, and an anti-angiotensin-converting
enzyme (ACE) antibody. B) Fraction 4 (F.4) was centrifuged and the supernatant (Sup) and pellet (PT) were probed with the anti-Prp P4-NT antibody and the anti-flotillin antibody. C) Extracts from the F.4 pellet were
deglycosylated by N-glycosidase F and probed with the P4-NT antibody.

form associates with these rafts. These findings are summarized in Figure 8.
We have previously shown that different Prp isoforms
are secreted by the epididymal epithelium [26]. By RT-PCR
and Northern blotting we have observed that Prp mRNA is
expressed in the testis and all regions of the epididymis
(unpublished results). Since Prp is encoded by a single exon
[41], differences in the prion isoforms must arise from posttranslational or postsecretory modifications. Thus, we employed three antibodies in order to establish the proteolytic
isoforms of prion present in the male reproductive tract: a
well-characterized monoclonal antibody directed against an
N-terminal peptide sequence [30] and two new antibodies
raised in our laboratory. The demonstrated specificity of
these antibodies has enabled us to identify both C-terminally and N-terminally truncated sheep prion isoforms. This
was important because conflicting results exist on the types
of truncated protein associated with sperm [27, 28]. Shaked
et al. [27] have described in human, bull, hamster, and
mouse that a C-terminal truncated prion was associated
with sperm, a finding consistent with these results and our
previous data in the ram. Meanwhile, Peoc’h et al. [28]
reported in mature human sperm the presence of an Nterminal truncated protein that, following treatment of ejaculated sperm with PI-PLC, resulted in a reduction in Prp
staining (as measured by flow cytometry), thus leading to
their suggestion that the protein is GPI-anchored.

The results obtained here with the new antibodies confirmed and emphasized our previous work [26] and show
that the main Prp isoform associated with ram sperm is Cterminally truncated. This, along with the failure of Triton
X-114 to extract the protein from sperm, indicates it does
not retain its GPI anchor in these cells. Moreover, we demonstrate that this Prp isoform is present in sperm as they
leave the testis and that there is no significant increase in
the amount of this isoform associated with cauda or ejaculated sperm (see Fig. 6A). Thus, it is concluded that this
isoform does not arise as a result of proteolytic cleavage
during epididymal maturation or upon ejaculation, or during protein transfer from the epididymal fluid. As reported
for humans [27], we show that the unglycosylated form of
this sperm-associated Prp is approximately 17 kDa. The
failure of both the 179-CT antibody and an antiserum that
preferentially recognizes the glutamate at residue 200 [27,
42] (corresponding to Glu203 in the ovine Prp sequence)
to detect this band in sperm extracts suggests that it is generated by cleavage at a site N-terminal to residue 203 (see
Fig. 8). However, it retains at least one N-glycosylation site
(Asn184), and the 8 kDa change in its apparent mass upon
deglycosylation suggests it is a monoglycosylated isoform.
As well, it implies the disruption of the disulfide bond between Cys182 and Cys217, which may be significant as
this intermolecular bonding has been reported to provide
stability to the C-terminal domain and play an important
role in the conversion of PrpC to PrpSC [43].
Previous work using mouse and guinea pig sperm have
localized caveolin-1, a protein known to associate with lipid
rafts, to both the sperm acrosome and flagellum [44]. We
have shown that despite being C-terminally truncated, some
Prp of mature ram sperm is found in these rafts. Thus, prion
may associate with these rafts through a GPI-independent
mechanism. The failure of Shaked et al. [27] to detect prion
in lipid rafts may be due to the majority of the protein being
localized to the cytoplasmic droplets of sperm [45]; however, these were also found to be rich in caveolin-1 in
mouse sperm [44]. We have overcome this problem by using sperm devoid of their cytoplasmic droplets in the flotation assay so that the results are not confounded by proteins arising from these droplets. Although the GPI-anchor
is an exoplasmic determinant of raft association, a number
of recent cell-free studies have clearly demonstrated the
interaction of Prp with model membranes, including sphingolipid-cholesterol-rich raftlike liposomes, can occur in a
GPI-independent manner [46–48]. These findings have
been confirmed in a recent study using a neuroblastoma cell
line, which reports that Prp contains a determinate within
the 23–90 N-terminal ectodomain that can mediate lipid raft
association independently of the GPI-anchor [49].
Our data suggests that there is a partitioning of the different biochemical isoforms of the protein between the fluid
phase and cellular phase within the male reproductive tract
with little transfer between the two. Significantly, this might
be achieved by posttranslational modifications of the protein (such as proteolytic cleavage and glycosylation) in order to impart a specific localization and functionality on
particular Prp isoforms. In this respect, because mature
sperm represent cells with no capacity for gene transcription, studies utilizing sperm from Prp-knockout and wildtype mice, as well as mice overexpressing the Prnp gene,
should provide a good model in which to study Prp isoform
function.
Interestingly, although the Prnp gene is transcribed
throughout the epididymis, and Prp is secreted under dif-
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FIG. 8. A schematic drawing of the Prp isoforms present in the male reproductive tract. Full-length, as well as C-terminally truncated and N-terminally
truncated, isoforms of Prp are compartmentalized between the sperm, reproductive fluid, and membrane vesicles (epididymosomes).

ferent forms by the epididymal epithelium [26], recent results from our laboratory suggest that glycosylation occurs
intracellularly and proteolysis most likely takes place in the
luminal fluid (unpublished data). Since Prp was mainly detected in large quantities in the fluid from the distal (cauda)
epididymis, this could indicate that proteolytic degradation
of Prp occurs in more proximal regions of the epididymis.
Proteolytic processing of the isoforms was also found to
occur upon ejaculation, although Prp was still found in both
soluble and membrane vesicle-associated forms. The majority of the Prp associated with seminosomes most likely
arises from epididymosomes, because the latter represents
the main source of vesicles present in this fluid [39].
The major immunoreactive bands in the cauda epididymal fluid were the heterodisperse 43 and 35 kDa forms and
a faint 28 kDa band. Upon deglycosylation, the main immunoreactive band in the fluid was at 25 kDa and corresponded to full-length Prp. The 43 kDa band most likely
represents the biglycosylated product of this full-length protein; biglycosylation therefore accounts for about 15–18
kDa of the apparent molecular mass of the mature protein
in the fluid. Our results indicate that glycosylated products
of this full-length prion isoform may retain its GPI-anchor
because the prion isoforms partitioned into the detergentrich phase following phase separation with Triton X-114.
Alternatively, cleaved Prp may exist in a hydrophobic complex with other proteins. This could explain why we failed
to detect the C-terminally truncated isoform in the aqueous
phase following the phase separation. We have attempted
to release Prp from epididymosomes by incubating them
with PI-PLC, but incubation at 378C had a deleterious effect
on the integrity of the membrane vesicles and could not be
used to assess Prp release into the surrounding medium.
Furthermore, treatment of cauda epididymal fluid with PIPLC failed to result in a shift of the Prp isoforms from the
detergent-rich phase to the aqueous phase or a change in
the relative mobility of the protein on an SDS-PAGE gel

[10, 50]. In contrast, when brain extracts from scrapie-infected mice were treated with PI-PLC Prp partitioned into
the aqueous phase following Triton X-114 phase separation,
the characteristic mobility shift in the GPI-anchorless form
could be clearly detected following separation on an SDSPAGE gel (data not shown). This may indicate that soluble
Prp in the cauda epididymal fluid is resistant to cleavage
by PI-PLC in a similar manner to that reported for another
GPI-containing protein present in epididymal fluid, PH20
[51]. Definitive evidence for the presence of a GPI-anchor
on the Prp present in the reproductive fluid will require
studies involving the purification and direct structural determination of the anchor using techniques such as mass
spectroscopy and/or metabolic labeling experiments using
epididymal tissue.
The presence of the heterodisperse band at 35 kDa probably represents glycosylated products of the C-terminally
and N-terminally truncated unglycosylated isoforms of 20
and 18 kDa, respectively (see Fig. 8). The 32–35 kDa band
may also be due to small levels of monoglycosylated fulllength product. The faint 28 kDa band could represent
monoglycosylated products of the terminally truncated isoforms as well as unglycosylated full-length protein. The 18
kDa C-terminal fragment detected in the fluid is probably
analogous to the C1 terminal fragment reported in brain
extracts that is cleaved at His-111 or Met-112 of the human
sequence [52], because this facilitates the generation of a
form that is not detected by the P4 antibody. This cleavage
is thought to be part of the normal metabolic processing of
the protein [52]. The 20 kDa N-terminal fragment detected
in the fluid is distinct from that found in sperm. It presumably arises from a different proteolytic cleavage mechanism
at a site downstream from that which generates the spermassociated isoform. Cleavage most likely occurs in the region 197–218 because this would generate a 20 kDa unglycosylated isoform not detected by the 179-CT antibody,
and our present results suggest that it retains both N-linked
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glycosylation sites. In the male genital tract, whether these
proteolytic cleavage products represent the degradation of
the full-length protein or functional isoforms of the protein
has not been established. At least some of the same isoforms were found to be associated with epididymosomes
and soluble in the fluid, raising questions as to the mechanism by which these two pools of protein are compartmentalized.
In conclusion, the findings of this study show definitively that both glycoyltic and proteolytic isoforms of Prp are
present within the reproductive fluid and gamete of the
male. We provide the first evidence for a C-terminally truncated prion isoform associated with lipid rafts in sperm and
retains at least one N-glycosylation site. Our results also
show that in the male reproductive fluid, Prp exists as a
full-length protein and in C-terminally truncated and Nterminally truncated isoforms. Part of the fluid protein is
associated with epididymosomes, but the mechanism by
which this ‘‘membrane’’-associated protein is also able to
exist in a ‘‘soluble circulating’’ state within this fluid warrants further investigation.
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